Oxford Asset Management’s Nu Skin NUS Stock Holding History

Oxford Asset Management’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-16,613	Closed	-$122K	–	559
2024 Q3	$122K	Buy	+16,613	New	+$155K	0.1%	272
2020 Q1	–	Sell	-14,037	Closed	-$575K	–	929
2019 Q4	$575K	Sell	14,037 -10,505	-43%	-$429K	0.02%	1167
2019 Q3	$1.04M	Buy	24,542 +8,417	+52%	+$353K	0.03%	927
2019 Q2	$795K	Buy	16,125 +8,953	+125%	+$455K	0.02%	1083
2019 Q1	$343K	Buy	+7,172	New	+$435K	0.01%	1372
2018 Q4	–	Sell	-2,599	Closed	-$213K	–	1987
2018 Q3	$213K	Sell	2,599 -39,139	-94%	-$3.11M	﹤0.01%	1587
2018 Q2	$3.28M	Sell	41,738 -37,218	-47%	-$2.88M	0.06%	362
2018 Q1	$5.82M	Sell	78,956 -9,633	-11%	-$684K	0.12%	158
2017 Q4	$6.07M	Buy	88,589 +10,446	+13%	+$676K	0.13%	179
2017 Q3	$4.83M	Buy	78,143 +8,647	+12%	+$531K	0.09%	234
2017 Q2	$4.37M	Sell	69,496 -16,708	-19%	-$952K	0.09%	242
2017 Q1	$4.79M	Buy	+86,204	New	+$4.44M	0.12%	159

Other funds holding NUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Oxford Asset Management's NUS Position: Q4 2024 in Review

Oxford Asset Management sold out of Nu Skin (NUS) in Q4 2024, closing a stake of 16,613 shares — an estimated $122K sold.

Oxford Asset Management first reported a position in NUS in Q1 2017 and held it in 12 quarters. The position peaked at $6.07M in Q4 2017. 200 funds tracked by Wall St. Rank hold NUS as of Q4 2024.

Oxford Asset Management reported no remaining Nu Skin position as of Q4 2024 after selling out during the quarter.
Oxford Asset Management sold 16,613 Nu Skin shares in Q4 2024, an estimated $122K.
Oxford Asset Management first reported a position in Nu Skin in Q1 2017 and held it in 12 quarters.
Oxford Asset Management's Nu Skin position peaked at $6.07M in Q4 2017.
200 funds tracked by Wall St. Rank held Nu Skin as of Q4 2024.

Based on Oxford Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.